{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T22:41:35Z","timestamp":1789684895772,"version":"4.0.1"},"reference-count":42,"publisher":"Portland Press Ltd.","issue":"4","license":[{"start":{"date-parts":[[2019,9,9]],"date-time":"2019-09-09T00:00:00Z","timestamp":1567987200000},"content-version":"vor","delay-in-days":161,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["portlandpress.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2019,4,30]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>microRNAs (miRNA), as tumor suppressors or oncogenes, are involved in modulating cancer cell behavior, including cell proliferation and apoptosis. The miR-140-5p acts as a tumor suppressor in several tumors, but the role of miR-140-5p in chronic myeloid leukemia (CML) remains unclear. Here, we investigated the suppression of miR-140-5p in CML patients and CML cell lines using quantitative PCR (qPCR) and fluorescence in situ hybridization (FISH). Overexpression miR-140-5p in CML cells significantly inhibited cell proliferation as revealed by the CCK-8 assay and promoted cell apoptosis as revealed by flow cytometry. Moreover, the sine oculis homeobox 1 (SIX1) gene had been confirmed as a direct target of miR-140-5p using bioinformatics analysis and luciferase reporter assays. Overexpression of miR-140-5p decreased the SIX1 protein level in CML cells. SIX1 mRNA and protein levels were significantly up-regulated in CML patients and CML cell lines. Knockdown of SIX1 expression significantly inhibited CML cell proliferation and promoted cell apoptosis. Furthermore, SIX1 as a transcriptional factor positively regulated pyruvate kinase isozyme type\u00a0M2 (PKM2) expression and played an important role in the Warburg effect. In addition, these findings indicated that miR-140-5p functions as a tumor suppressor and plays a critical role in CML cell apoptosis and metabolism by targeting SIX1. Moreover, the miR-140-5p\/SIX1 axis may be a potential therapeutic target in CML.<\/jats:p>","DOI":"10.1042\/bsr20190150","type":"journal-article","created":{"date-parts":[[2019,4,30]],"date-time":"2019-04-30T12:29:21Z","timestamp":1556627361000},"update-policy":"https:\/\/doi.org\/10.1042\/crossmark_policy","source":"Crossref","is-referenced-by-count":34,"title":["miR-140-5p induces cell apoptosis and decreases Warburg effect in chronic myeloid leukemia by targeting SIX1"],"prefix":"10.1042","volume":"39","author":[{"given":"Zi-Yuan","family":"Nie","sequence":"first","affiliation":[{"name":"Department of Hematology, The Second Hospital of Hebei Medical University, 215 Heping W Rd, Shijiazhuang 050000, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao-Jun","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Hematology, The Second Hospital of Hebei Medical University, 215 Heping W Rd, Shijiazhuang 050000, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Zhan","sequence":"additional","affiliation":[{"name":"Department of Hematology, The Second Hospital of Hebei Medical University, 215 Heping W Rd, Shijiazhuang 050000, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meng-Han","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Hematology, The Second Hospital of Hebei Medical University, 215 Heping W Rd, Shijiazhuang 050000, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao-Yan","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Hematology, The Second Hospital of Hebei Medical University, 215 Heping W Rd, Shijiazhuang 050000, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zi-Ye","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Hematology, The Second Hospital of Hebei Medical University, 215 Heping W Rd, Shijiazhuang 050000, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ya-Qiong","family":"Lu","sequence":"additional","affiliation":[{"name":"Department of Hematology, The Second Hospital of Hebei Medical University, 215 Heping W Rd, Shijiazhuang 050000, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8811-7187","authenticated-orcid":false,"given":"Jian-Min","family":"Luo","sequence":"additional","affiliation":[{"name":"Department of Hematology, The Second Hospital of Hebei Medical University, 215 Heping W Rd, Shijiazhuang 050000, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lin","family":"Yang","sequence":"additional","affiliation":[{"name":"Department of Hematology, The Second Hospital of Hebei Medical University, 215 Heping W Rd, Shijiazhuang 050000, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"288","published-online":{"date-parts":[[2019,4,30]]},"reference":[{"key":"2021111619252613800_B1","doi-asserted-by":"publisher","first-page":"1441","DOI":"10.1002\/1097-0142(19880401)61:7%3c1441::AID-CNCR2820610727%3e3.0.CO;2-C","article-title":"Characteristics of accelerated disease in chronic myelogenous leukemia","volume":"61","author":"Kantarjian","year":"1988","journal-title":"Cancer"},{"key":"2021111619252613800_B2","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1182\/blood.V82.3.691.691","article-title":"Chronic myelogenous leukemia: a concise update","volume":"82","author":"Kantarjian","year":"1993","journal-title":"Blood"},{"key":"2021111619252613800_B3","doi-asserted-by":"publisher","first-page":"1451","DOI":"10.1056\/NEJMra020777","article-title":"Chronic myeloid leukemia\u2013advances in biology and new approaches to treatment","volume":"349","author":"Goldman","year":"2003","journal-title":"N. Engl. J. Med."},{"key":"2021111619252613800_B4","doi-asserted-by":"publisher","first-page":"917","DOI":"10.1056\/NEJMoa1609324","article-title":"Long-term outcomes of imatinib treatment for chronic myeloid leukemia","volume":"376","author":"Hochhaus","year":"2017","journal-title":"N. Engl. J. Med."},{"key":"2021111619252613800_B5","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1038\/nrg1379","article-title":"MicroRNAs: small RNAs with a big role in gene regulation","volume":"5","author":"He","year":"2004","journal-title":"Nat. Rev. Genet."},{"key":"2021111619252613800_B6","doi-asserted-by":"publisher","first-page":"1529","DOI":"10.1016\/j.ejca.2007.04.002","article-title":"The role of microRNAs in cancer: no small matter","volume":"43","author":"Wiemer","year":"2007","journal-title":"Eur. J. Cancer"},{"key":"2021111619252613800_B7","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1186\/s12943-015-0465-3","article-title":"MiR-362-5p promotes the malignancy of chronic myelocytic leukaemia via down-regulation of GADD45alpha","volume":"14","author":"Yang","year":"2015","journal-title":"Mol. Cancer"},{"key":"2021111619252613800_B8","doi-asserted-by":"publisher","first-page":"12460","DOI":"10.1038\/srep12460","article-title":"MicroRNA-320a acts as a tumor suppressor by targeting BCR\/ABL oncogene in chronic myeloid leukemia","volume":"5","author":"Xishan","year":"2015","journal-title":"Sci. Rep."},{"key":"2021111619252613800_B9","first-page":"4308","article-title":"MiR-15a-5p negatively regulates cell survival and metastasis by targeting CXCL10 in chronic myeloid leukemia","volume":"9","author":"Chen","year":"2017","journal-title":"Am. J. Transl. Res."},{"key":"2021111619252613800_B10","doi-asserted-by":"publisher","first-page":"1302","DOI":"10.1182\/blood-2014-06-581926","article-title":"MicroRNA-486 regulates normal erythropoiesis and enhances growth and modulates drug response in CML progenitors","volume":"125","author":"Wang","year":"2015","journal-title":"Blood"},{"key":"2021111619252613800_B11","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1186\/s12943-017-0708-6","article-title":"miR-140-5p suppresses the proliferation, migration and invasion of gastric cancer by regulating YES1","volume":"16","author":"Fang","year":"2017","journal-title":"Mol. Cancer"},{"key":"2021111619252613800_B12","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1002\/hep.26315","article-title":"MicroRNA-140-5p suppresses tumor growth and metastasis by targeting transforming growth factor beta receptor 1 and fibroblast growth factor 9 in hepatocellular carcinoma","volume":"58","author":"Yang","year":"2013","journal-title":"Hepatology"},{"key":"2021111619252613800_B13","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1007\/s00018-008-8335-4","article-title":"The sine oculis homeobox (SIX) family of transcription factors as regulators of development and disease","volume":"66","author":"Kumar","year":"2009","journal-title":"Cell. Mol. Life Sci."},{"key":"2021111619252613800_B14","doi-asserted-by":"publisher","first-page":"2668","DOI":"10.1158\/0008-5472.CAN-04-4286","article-title":"Gene amplification is a mechanism of Six1 overexpression in breast cancer","volume":"65","author":"Reichenberger","year":"2005","journal-title":"Cancer Res."},{"key":"2021111619252613800_B15","doi-asserted-by":"publisher","first-page":"3036","DOI":"10.1158\/0008-5472.CAN-06-3755","article-title":"Six1 overexpression in ovarian carcinoma causes resistance to TRAIL-mediated apoptosis and is associated with poor survival","volume":"67","author":"Behbakht","year":"2007","journal-title":"Cancer Res."},{"key":"2021111619252613800_B16","doi-asserted-by":"publisher","first-page":"4923","DOI":"10.1038\/onc.2011.646","article-title":"SIX1 promotes epithelial-mesenchymal transition in colorectal cancer through ZEB1 activation","volume":"31","author":"Ono","year":"2012","journal-title":"Oncogene"},{"key":"2021111619252613800_B17","doi-asserted-by":"publisher","first-page":"368e7","DOI":"10.1016\/j.ccell.2018.01.010","article-title":"Transcriptional regulation of the Warburg effect in cancer by SIX1","volume":"33","author":"Li","year":"2018","journal-title":"Cancer Cell"},{"key":"2021111619252613800_B18","doi-asserted-by":"publisher","first-page":"1477","DOI":"10.1016\/j.bbadis.2015.04.012","article-title":"miR-155-dependent regulation of mammalian sterile 20-like kinase 2 (MST2) coordinates inflammation, oxidative stress and proliferation in vascular smooth muscle cells","volume":"1852","author":"Yang","year":"2015","journal-title":"Biochim. Biophys. Acta"},{"key":"2021111619252613800_B19","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1186\/s13046-017-0649-3","article-title":"Silencing of miR-193a-5p increases the chemosensitivity of prostate cancer cells to docetaxel","volume":"36","author":"Yang","year":"2017","journal-title":"J. Exp. Clin. Canc. Res."},{"key":"2021111619252613800_B20","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1038\/onc.2009.332","article-title":"Warburg effect revisited: an epigenetic link between glycolysis and gastric carcinogenesis","volume":"29","author":"Liu","year":"2010","journal-title":"Oncogene"},{"key":"2021111619252613800_B21","doi-asserted-by":"publisher","first-page":"242513","DOI":"10.1155\/2013\/242513","article-title":"PKM2, a central point of regulation in cancer metabolism","volume":"2013","author":"Wong","year":"2013","journal-title":"Int. J. Cell Biol."},{"key":"2021111619252613800_B22","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/bs.ircmb.2017.03.007","article-title":"A macro view of microRNAs: the discovery of microRNAs and their role in hematopoiesis and hematologic disease","volume":"334","author":"Weiss","year":"2017","journal-title":"Int. Rev. Cel. Mol. Biol."},{"key":"2021111619252613800_B23","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1186\/1476-4598-10-41","article-title":"Expression patterns of microRNAs associated with CML phases and their disease related targets","volume":"10","author":"Machova Polakova","year":"2011","journal-title":"Mol. Cancer"},{"key":"2021111619252613800_B24","doi-asserted-by":"publisher","first-page":"311","DOI":"10.3322\/caac.21244","article-title":"MicroRNAome genome: a treasure for cancer diagnosis and therapy","volume":"64","author":"Berindan-Neagoe","year":"2014","journal-title":"CA Cancer J. Clin."},{"issue":"1","key":"2021111619252613800_B25","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1186\/s12943-017-0708-6","article-title":"miR-140-5p suppresses the proliferation, migration and invasion of gastric cancer by regulating YES1","volume":"16","author":"Fang","year":"2017","journal-title":"Mol. Cancer"},{"key":"2021111619252613800_B26","doi-asserted-by":"publisher","first-page":"1466","DOI":"10.1159\/000366351","article-title":"Down-regulation of miR-140 induces EMT and promotes invasion by targeting Slug in esophageal cancer","volume":"34","author":"Li","year":"2014","journal-title":"Cell. Physiol. Biochem."},{"key":"2021111619252613800_B27","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/j.biopha.2015.07.035","article-title":"miR-140-5p inhibits ovarian cancer growth partially by repression of PDGFRA","volume":"75","author":"Lan","year":"2015","journal-title":"Biomed. Pharmacother."},{"key":"2021111619252613800_B28","doi-asserted-by":"publisher","first-page":"68397","DOI":"10.18632\/oncotarget.11722","article-title":"MicroRNA-140-5p targets insulin like growth factor 2 mRNA binding protein 1 (IGF2BP1) to suppress cervical cancer growth and metastasis","volume":"7","author":"Su","year":"2016","journal-title":"Oncotarget"},{"key":"2021111619252613800_B29","doi-asserted-by":"publisher","first-page":"4923","DOI":"10.1038\/onc.2011.646","article-title":"SIX1 promotes epithelial-mesenchymal transition in colorectal cancer through ZEB1 activation","volume":"31","author":"Ono","year":"2012","journal-title":"Oncogene"},{"key":"2021111619252613800_B30","doi-asserted-by":"publisher","first-page":"1071","DOI":"10.2147\/OTT.S125330","article-title":"SIX1 overexpression predicts poor prognosis and induces radioresistance through AKT signaling in esophageal squamous cell carcinoma","volume":"10","author":"He","year":"2017","journal-title":"Oncotargets Ther."},{"issue":"3","key":"2021111619252613800_B31","doi-asserted-by":"publisher","first-page":"e59203","DOI":"10.1371\/journal.pone.0059203","article-title":"Six1 promotes proliferation of pancreatic cancer cells via upregulation of cyclin D1 expression","volume":"8","author":"Li","year":"2013","journal-title":"PLoS ONE"},{"key":"2021111619252613800_B32","doi-asserted-by":"publisher","first-page":"1029","DOI":"10.1126\/science.1160809","article-title":"Understanding the Warburg effect: the metabolic requirements of cell proliferation","volume":"324","author":"Vander Heiden","year":"2009","journal-title":"Science"},{"key":"2021111619252613800_B33","doi-asserted-by":"publisher","first-page":"618","DOI":"10.1038\/nrc3108","article-title":"Otto Warburg\u2019s contributions to current concepts of cancer metabolism (vol 11, pg 325, 2011)","volume":"11","author":"Koppenol","year":"2011","journal-title":"Nat. Rev. Cancer"},{"key":"2021111619252613800_B34","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1038\/nrc1478","article-title":"Why do cancers have high aerobic glycolysis?","volume":"4","author":"Gatenby","year":"2004","journal-title":"Nat. Rev. Cancer"},{"key":"2021111619252613800_B35","doi-asserted-by":"publisher","first-page":"3685","DOI":"10.1172\/JCI69741","article-title":"Targeting lactate metabolism for cancer therapeutics","volume":"123","author":"Doherty","year":"2013","journal-title":"J. Clin. Invest."},{"key":"2021111619252613800_B36","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1016\/j.canlet.2014.01.031","article-title":"PKM2 contributes to cancer metabolism","volume":"356","author":"Wong","year":"2015","journal-title":"Cancer Lett."},{"key":"2021111619252613800_B37","doi-asserted-by":"publisher","first-page":"23803","DOI":"10.1074\/jbc.M115.657411","article-title":"ERK2-pyruvate kinase axis permits phorbol 12-myristate 13-acetate-induced megakaryocyte differentiation in K562 cells","volume":"290","author":"Chaman","year":"2015","journal-title":"J. Biol. Chem."},{"key":"2021111619252613800_B38","doi-asserted-by":"publisher","first-page":"8202","DOI":"10.18632\/oncotarget.1159","article-title":"Tissue-specific isoform switch and DNA hypomethylation of the pyruvate kinase PKM gene in human cancers","volume":"5","author":"Desai","year":"2014","journal-title":"Oncotarget"},{"key":"2021111619252613800_B39","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1038\/nature08697","article-title":"HnRNP proteins controlled by c-Myc deregulate pyruvate kinase mRNA splicing in cancer","volume":"463","author":"David","year":"2010","journal-title":"Nature"},{"key":"2021111619252613800_B40","doi-asserted-by":"publisher","first-page":"2054","DOI":"10.3892\/or.2015.4175","article-title":"MicroRNA-122 affects cell aggressiveness and apoptosis by targeting PKM2 in human hepatocellular carcinoma","volume":"34","author":"Xu","year":"2015","journal-title":"Oncol. Rep."},{"key":"2021111619252613800_B41","doi-asserted-by":"publisher","first-page":"e12510","DOI":"10.1111\/cpr.12510","article-title":"MiR-139-5p is associated with poor prognosis and regulates glycolysis by repressing PKM2 in gallbladder carcinoma","volume":"51","author":"Chen","year":"2018","journal-title":"Cell Prolif."},{"key":"2021111619252613800_B42","doi-asserted-by":"publisher","first-page":"4129","DOI":"10.1073\/pnas.1014769108","article-title":"Mammalian target of rapamycin up-regulation of pyruvate kinase isoenzyme type M2 is critical for aerobic glycolysis and tumor growth","volume":"108","author":"Sun","year":"2011","journal-title":"Proc. Natl. Acad. Sci. U.S.A."}],"container-title":["Bioscience Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/portlandpress.com\/bioscirep\/article-pdf\/doi\/10.1042\/BSR20190150\/842268\/bsr-2019-0150.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/portlandpress.com\/bioscirep\/article-pdf\/doi\/10.1042\/BSR20190150\/842268\/bsr-2019-0150.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,11,16]],"date-time":"2021-11-16T20:18:52Z","timestamp":1637093932000},"score":1,"resource":{"primary":{"URL":"https:\/\/portlandpress.com\/bioscirep\/article\/39\/4\/BSR20190150\/110816\/miR-140-5p-induces-cell-apoptosis-and-decreases"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,4]]},"references-count":42,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2019,4,30]]}},"URL":"https:\/\/doi.org\/10.1042\/bsr20190150","relation":{},"ISSN":["0144-8463","1573-4935"],"issn-type":[{"value":"0144-8463","type":"print"},{"value":"1573-4935","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2019,4]]},"published":{"date-parts":[[2019,4]]},"article-number":"BSR20190150"}}